Related Experiment Video
Updated: Apr 13, 2026

08:05
Multiplexed Fluorometric ImmunoAssay Testing Methodology and Troubleshooting
Published on: December 12, 2011
29.0K
An interlaboratory transfer of a multi-analyte assay between continents
Alexandra Georgiou1, Kelly Dong, Stephen Hughes
1Bioanalytical Science & Toxicokinetics, Drug Metabolism & Pharmacokinetics, GlaxoSmithKline Research & Development, Ware, UK.
Bioanalysis
|May 2, 2015
Summary
Assay transfer and cross-validation between laboratories present significant technical and logistical challenges. Thorough planning and clear communication are crucial for successful assay transfer and data integrity in bioanalysis.
Area of Science:
- Pharmaceutical Sciences
- Analytical Chemistry
- Drug Development
Background:
- Bioanalytical and toxicokinetic studies are critical throughout drug development.
- Outsourcing bioanalysis to Contract Research Organizations (CROs) is a common strategy.
- Ensuring data quality and regulatory compliance during assay transfer is paramount.
Purpose of the Study:
- To highlight the challenges encountered during bioanalytical assay transfer and cross-validation between laboratories.
- To emphasize the importance of planning and communication in overcoming these challenges.
- To illustrate best practices for successful assay transfer and validation in a global context.
Main Methods:
- Case study approach detailing assay transfer and cross-validation processes.
- Focus on technical and logistical challenges in inter-laboratory assay transfer.
- Examination of investigation procedures following failed cross-validation.
Main Results:
- Assay transfer and cross-validation between different laboratories, especially across continents, can be complex.
- Technical and logistical hurdles can significantly impact timelines and data reliability.
- Successful transfer requires robust planning, effective communication, and rigorous investigation protocols.
Conclusions:
- Effective assay transfer and cross-validation are essential for maintaining data integrity in drug development.
- Proactive planning and open communication between all parties are critical for mitigating risks.
- This case study underscores the necessity of a systematic approach to ensure quality bioanalytical data from outsourced studies.

